HMBD-009

N/A

Report date: 2025/03/21 16:53:58

Base Information

Drug NameHMBD-009
Drug Alias NameNext-Generation BCMA-TACI Dual-Specific T Cell EngagerHMBD-009
ClassificationBiologics
Mechanisms of ActionB-cell maturation protein modulatorsTumor necrosis factor receptor superfamily member 13B modulators
TargetsB-cell maturation proteinTumor necrosis factor receptor superfamily member 13B
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHummingbird Bioscience
China Registration ClassN/A

Develop Information

Active CompaniesHummingbird Bioscience
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A